Pharmacy & Formulary Resources

• Products Recalled
  Recalled Medication: ACETIC ACID 2% EAR SOLUTION
  Recalled Medication: CICLOPIROX 8% SOLUTION
  Recalled Medication: FLUTICASONE PROP 50 MCG SPRAY
  Recalled Medication: GUAIATUSSIN AC LIQUID
  Recalled Medication: HYDROCORTISONE-ACETIC ACID SOLUTION
  Recalled Medication: LACTULOSE 10 GM/15 ML SOLUTION
  Recalled Medication: LIDOCAINE 2% VISCOUS SOLUTION
  Recalled Medication: LIDOCAINE-PRILOCAINE CREAM
  Recalled Medication: PILOCARPINE 1% EYE DROPS
  Recalled Medication: PROMETHAZINE 6.25 MG/5 ML SOLUTION
  Recalled Medication: PROMETHAZINE-CODEINE SYRUP
  Manufacturer: Akorn Operating Company LLC
  Recall Date: April 26, 2023
  Reason: As a result of a bankruptcy, the firm is removing several products from the market due to the discontinuation of the Quality program which would result in the company’s inability to assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess which render the products adulterated.
  FDA Notice
• Recalled Medication: IDArubicin Hydrochloride Injection USP 5 mg/5 mL
  Manufacturer: Teva Pharmaceuticals
  Recall Date: 03/29/2022
  Reason: Potential Particulate Matter (silica and iron oxide)
  FDA Notice

• CHANTIX
  Recalled Medication: Chantix, Varenicline tablets
  Manufacturer: Pfizer
  Recall Date: 09/16/2021
  Reason: N-nitroso-varenicline above acceptable daily intake level
  FDA Notice
• CHANTIX® (Varenicline) Tablets
  Recalled Medication: Chantix
  Manufacturer: Pfizer
  Recall Date: 07/16/2021
  Reason: N-Nitroso Varenicline content above ADI level
  FDA Notice
• Recalled Medication: Paroex Chlorhexidine Gluconate Oral Rinse, 4 oz and 16 oz
  Manufacturer: Sunstar Americas, Inc.
  Recall Date: 12/28/2020
  Reason: Potential contamination with Burkholderia lata
  FDA Notice
• Recalled Medication: Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg
  Manufacturer: Marksans Pharma Limited
  Recall Date: 10/05/2020
  Reason: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
  FDA Notice
• Recalled Medication: Albuterol Sulfate Inhalation Aerosol
  Manufacturer: Catalent Pharma Solutions for Perrigo Pharmaceutical Company
  Recall Date: 09/21/2020
  Reason: Due to possible clogging of the inhaler resulting in patients not receiving enough or any medicine.
  FDA Notice
• DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL
  Manufacturer: Ferring Pharmaceuticals US
  Recall Date: 08/05/2020
  Reason: These products are being recalled due to superpotency or amounts of desmopressin higher than specified.
  FDA Notice
• Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg
  Manufacturer: Lupin Pharmaceuticals, Inc.
  Recall Date: 07/08/2020
  Reason: Due to the detection of N-Nitrosodimethylamine (NDMA).
  FDA Notice
• Metformin Hydrochloride Extended-Release Tablets USP, 750mg
  Manufacturer: Granules Pharmaceuticals, Inc.
  Recall Date: 07/03/2020
  Reason: Due to the detection of N-Nitrosodimethylamine (NDMA).
  FDA Notice
• Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
  Manufacturer: Amneal Pharmaceuticals LLC
  Recall Date: 05/29/2020
  Reason: Due to detection of N-Nitrosodimethylamine (NDMA).
  FDA Notice
• Metformin Hydrochloride Extended-Release Tablets, USP 500mg
  Manufacturer: Apotex Corp.
  Recall Date: 05/27/2020
  Reason: Due to detection of N-Nitrosodimethylamine (NDMA).
  FDA Notice
• All Ranitidine Products (Zantac)
  Manufacturer: All
  Recall Date: 04/01/2020
  Reason: Ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) which is a probable human carcinogen (a substance that could cause cancer).
  FDA Notice

• Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL
  Manufacturer: Amneal Pharmaceuticals, LLC
  Recall Date: 11/08/2019
  Reason: Due to potential N-Nitrosodimethylamine (NDMA) amounts being above levels established by the FDA.
  FDA Notice
• Ranitidine Tablets 150mg, Ranitidine Capsules 150 mg, Ranitidine Capsules 300 mg and Ranitidine Syrup 15 mg/mLRanitidine Tablets, Capsules, and Syrup
  Manufacturer: Aurobindo Pharma USA, Inc.
  Recall Date: 11/06/2019
  Reason: Due to the detection of Nitrosodimethylamine (NDMA) impurity.
  FDA Notice
• Ranitidine Syrup (Oral Solution, USP), 15 mg/mL
  Manufacturer: Lannett Company, Inc.
  Recall Date: 10/25/2019
  Reason: Due to levels of N-Nitrosodimethylamine (NDMA) being above the levels recently established by the FDA.
  FDA Notice
• Ranitidine Tablets & Capsules
  Manufacturer: Dr. Reddy’s Laboratories Ltd.
  Recall Date: 10/23/2019
  Reason: Contamination with N-Nitrosodimethylamine (NDMA) above the levels established by the FDA.
  FDA Notice
• Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg
  Recall Date: 06/26/2019
  Manufacturer: Macleods Pharmaceuticals, Ltd.
  Reason: Detection of trace amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the interim acceptable daily intake levels released by the FDA.
  FDA Notice 
• Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg
  Recall Date: 02/22/2019
  Manufacturer: Macleods Pharmaceuticals, Ltd.
  Reason: Detection of trace amounts of an unexpected impurity (NDEA) above the interim acceptable daily intake levels released by the FDA.
  FDA Notice 
• Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
  Recall Date: 01/22/19
  Manufacturer: Torrent Pharmaceuticals Limited
  Reason: Detection of trace amounts of an N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.
  FDA Notice 
• Irbesartan and Irbesartan HCTZ Tablets
  Recall Date: 01/18/2019
  Manufacturer: Prinston Pharmaceutical Inc. dba Solco Healthcare LLC
  Reason: Detection of trace amount of N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.
  FDA Notice
• Valsartan and Valsartan-HCTZ Tablets, USP
  Recall Date: 07/18/2018
  Manufacturers: Prinston Pharmaceuticals, and TEVA Pharmaceuticals.
  Reason: It has been found that the recalled products for impurity detected. This may cause unexpected health risks.
  FDA Notice – Prinston Pharmaceuticals
  FDA Notice – TEVA Pharmaceuticals

• Provider Alert: New Boxed Warning for Lunesta (eszopiclone), Sonata (zaleplon), Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist (zolpidem) (05/23/19)
• Provider Alert: Legacy Pharmaceutical Packaging, LLC – Losartan Potassium Tablets Medication Recall (03/15/19)
• Provider Alert: EpiPen Use (08/21/2018)
• Provider Alert: Levothyroxine and Liothyronine (Thyroid Tablets, USP) Medication Recall (08/09/2018)
• Provider Alert: Rugby Diocto Medication Recall (8/2017)
• Provider Alert: Hospira Issues a Voluntary Nationwide Recall (6/15/17)
• Provider Alert: All Topical Products made by Phillips Company Medication Recall (6/9/2017)
• Provider Alert: All Lots of Diocto Liquid, 50 mg/5 mL for NCD 0536-0590-85 Medication Recall (07/15/2016)
• Provider Alert: All Medications Compounded by Reliable Drug Medication Recall (3/25/2016)
• Provider Alert: Amikacin Sulfate Injection 1 gram per 4mL Medication Recall (03/09/2016)
• Provider Alert: Fluconzaole Injection 200mg per 100mL Medication Recall (03/01/2016)
• Provider Alert: Acetaminophen Tablets, 500mg Medication Recall (10/14/2015)
• Provider Alert: Auvi-Q Medication Recall (10/28/2015)